Strategic Financial Concepts LLC purchased a new position in shares of Abbott Laboratories (NYSE:ABT – Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The ...
According to Abbott's announcement, the money will support the tech company's research and development operations in Austin ...
Abbott Laboratories (NYSE:ABT) discovers, develops, manufactures and sells healthcare products worldwide. It is set to report ...
1d
Shares of Abbott Laboratories ABT rallied 1.50% to $132.13 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.24% to ...
The last few weekends have been roiled by headlines. Here's why we took a different direction on this medical stock this week ...
Abbott Laboratories (NYSE:ABT – Get Free Report) was downgraded by equities researchers at StockNews.com from a “strong-buy” ...
His fears were that Abbott (NYSE:ABT) might pull the product entirely rather than risk further lawsuits—just like Johnson & ...
Many Abbott Laboratories (NYSE:ABT) insiders ditched their stock over the past year, which may be of interest to the company's shareholders. When analyzing insider transactions, it is usually more ...
AUSTIN, Texas — Austin’s Silicon Laboratories has received a $23.3 million grant from the Texas Semiconductor Innovation Fund (TSIF), Gov. Greg Abbott announced on Wednesday. The grant will help fund ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback